Michael Schaeffer
Director/Board Member at VIVORYON THERAPEUTICS N.V.
Net worth: - $ as of 30/03/2024
Profile
Dr. Michael Schaeffer is an Executive Director & Chief Business Officer at Vivoryon Therapeutics NV.
He is on the Board of Directors at Vivoryon Therapeutics NV.
Dr. Schaeffer was previously employed as a Chief Executive Officer & Managing Director by Crelux GmbH and a Chief Executive Officer & Managing Director by SiREEN AG.
He received his doctorate degree from Ludwig-Maximilians-Universität München.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 03/03/2024 | 0 ( -.--% ) | - $ | 30/03/2024 |
Michael Schaeffer active positions
| Companies | Position | Start |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Director/Board Member | - |
Former positions of Michael Schaeffer
| Companies | Position | End |
|---|---|---|
Crelux GmbH
 Crelux GmbH BiotechnologyHealth Technology Crelux GmbH provides structure based drug discovery solutions. The firm provides customized services to support hit-finding, conformational analysis and lead optimization, including protein production, biophysical assays, fragment screening, and X-ray crystallography. It works for pharma, biotech and research organizations. The company was founded by Ismail Moarefi, Martin Ried and Michael Schaeffer and is headquartered in Martinsried, Germany. | Chief Executive Officer | 29/02/2016 |
| SiREEN AG | Chief Executive Officer | 31/12/2003 |
Training of Michael Schaeffer
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VIVORYON THERAPEUTICS N.V. | Health Technology |
| Private companies | 2 |
|---|---|
| SiREEN AG | Commercial Services |
Crelux GmbH
Crelux GmbH BiotechnologyHealth Technology Crelux GmbH provides structure based drug discovery solutions. The firm provides customized services to support hit-finding, conformational analysis and lead optimization, including protein production, biophysical assays, fragment screening, and X-ray crystallography. It works for pharma, biotech and research organizations. The company was founded by Ismail Moarefi, Martin Ried and Michael Schaeffer and is headquartered in Martinsried, Germany. | Health Technology |
- Stock Market
- Insiders
- Michael Schaeffer
